ArticleJournal for immunotherapy of cancer2025

Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models.

Manali S Phadke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.